Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

Bruce J Tromberg; Albert Cerussi; Natasha Shah; Montana Compton; Amanda Durkin; David Hsiang; John Butler; Rita Mehta

doi:10.1186/bcr1358

Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

Breast Cancer Research ◽

10.1186/bcr1358 ◽

2005 ◽

Vol 7 (6) ◽

Cited By ~ 172

Author(s):

Bruce J Tromberg ◽

Albert Cerussi ◽

Natasha Shah ◽

Montana Compton ◽

Amanda Durkin ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Diffuse Optics ◽

Menopausal Women

Download Full-text

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2013.00317 ◽

2013 ◽

Vol 3 ◽

Cited By ~ 2

Author(s):

David M. Marcus ◽

Jeffrey M. Switchenko ◽

Roshan Prabhu ◽

Ruth O’Regan ◽

Amelia Zelnak ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Hormonal Therapy ◽

Neoadjuvant Hormonal Therapy ◽

Menopausal Women ◽

Estrogen Receptor Positive ◽

Post Menopausal ◽

Positive Breast Cancer

Download Full-text

Abstract P6-15-08: Neoadjuvant chemotherapy vs neoadjuvant endocrine therapy in ER/PR positive HER-2 negative post-menopausal women with breast cancer, is one superior than other? A NCDB analysis

10.1158/1538-7445.sabcs17-p6-15-08 ◽

2018 ◽

Author(s):

A Basnet ◽

D Wang ◽

A Sivapiragasam

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Endocrine Therapy ◽

Neoadjuvant Endocrine Therapy ◽

Menopausal Women ◽

Her 2 ◽

Post Menopausal

Download Full-text

Exclusive radiation therapy after neoadjuvant chemotherapy for locally advanced breast cancer: experience of a single academic institution

European Journal of Cancer ◽

10.1016/s0959-8049(02)80501-9 ◽

2002 ◽

Vol 38 (11) ◽

pp. S150

Author(s):

J Caudrelier

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Academic Institution ◽

Advanced Breast ◽

Cancer Experience

Download Full-text

Association between gastrin-releasing peptide receptor expression based on Ga-68-RM2-PET and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer

10.1055/s-0039-1683576 ◽

2019 ◽

Author(s):

C Stoykow ◽

J Asberger ◽

H Maecke ◽

P Bronsert ◽

M Werner ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Primary Breast Cancer ◽

Tumor Regression ◽

Receptor Expression ◽

Peptide Receptor ◽

Gastrin Releasing Peptide

Download Full-text

Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS+EG score

10.1055/s-0039-1688026 ◽

2019 ◽

Author(s):

L Michel ◽

L Sommer ◽

R González Silos ◽

J Lorenzo Bermejo ◽

A von Au ◽

...

Keyword(s):

Breast Cancer ◽

Risk Assessment ◽

Neoadjuvant Chemotherapy ◽

Primary Breast Cancer ◽

Clinical Utility

Download Full-text

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Ki-67 CAN BE USED AS A PREDICTIVE FACTOR FOR THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

10.26226/morressier.599bdc7ad462b80296ca087f ◽

2017 ◽

Author(s):

Nejc Kozar

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Predictive Factor ◽

Breast Cancer Patients ◽

Ki 67

Download Full-text

3 / The value of tumour infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a study in a hospital complex

10.26226/morressier.5b4709876f4cb30010951a18 ◽

2018 ◽

Author(s):

Alicia Cordoba ◽

Alicia ['Tania'] ◽

David Guerrero Setas

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Tumour Infiltrating Lymphocytes ◽

Infiltrating Lymphocytes ◽

Response To Neoadjuvant Chemotherapy

Download Full-text

Atorvastatin in Treating Patients With Stages IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Case Medical Research ◽

10.31525/ct1-nct03872388 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Pathologic Complete Response ◽

Complete Response

Download Full-text

Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03982485 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy

Download Full-text